Halozyme Therapeutics
HALO
#1865
Rank
C$15.70 B
Marketcap
C$137.72
Share price
0.30%
Change (1 day)
38.91%
Change (1 year)

EPS for Halozyme Therapeutics (HALO)

EPS in 2026 (TTM): C$4.98

According to Halozyme Therapeutics's latest financial reports the company's current EPS (TTM) is C$5.04. In 2025 the company made an earnings per share (EPS) of C$3.73 a decrease over its 2024 EPS that were of C$5.01.

EPS history for Halozyme Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$4.9833.39%
2025C$3.73-25.43%
2024C$5.01
2022C$2.12-48.07%
2021C$4.08196.87%
2020C$1.37-292%
2019C-$0.72-9.09%
2018C-$0.79-237.5%
2017C$0.57-149.38%
2016C-$1.16211.54%
2015C-$0.37-52.73%
2014C-$0.79-24.66%
2013C-$1.0448.98%
2012C-$0.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.56 89.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.02-79.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.20 777.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.83-43.73%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
C-$2.02-140.06%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C-$0.19-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA